Radiologists call for national strategy to address medical imaging overuse

European Journal of Human Genetics - Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2)

Note: a quick outline highlighting Lynch Syndrome/mutations/rationale for genetic testing etc

abstract - Risky feelings: Why a 6% risk of cancer does not always feel like 6%

Objective
Emotion plays a strong role in the perception of risk information but is frequently underemphasized in the decision-making and communication literature. We sought to discuss and put into context several lines of research that have explored the links between emotion and risk perceptions.

in research; Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma

Long-term adjustment of survivors of ovarian cancer - abstract J Psychosoc Oncol. 2010

Abstract

This study described the long-term adjustment of 42 ovarian cancer survivors diagnosed with advanced-stage disease with no evidence of recurrence, a mean of 6.1 years postdiagnosis. 64% of survivors' mental health was at or above the norm of medical outpatients (Mental Health Inventory-17). No patients reported post-traumatic stress disorder at a diagnosable level (Post-Traumatic Stress Disorder (PTSD) Checklist-Civilian). The majority of survivors (>/= 75%) reported a positive impact of cancer on their lives (Impact of Cancer Scale) and excellent social support (Medical Outcomes Study Social Support Survey). However, a subset of survivors reported needing more help than was received regarding emotional problems (28.9%).

FDA approves injection concentrate formulation for docetaxel - - short article (U.S.)

Epidemiology: (abstract) Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen

Exploring the influence of service user involvement on health and social care services for cancer - Attree - 2010 - Health Expectations - UK study

Abstract

Background  Service user involvement in health and social care is a key policy driver in the UK. In cancer care it is central to developing services which are effective, responsive and accessible to patients. Cancer network partnership groups are set up to enable joint working between service users and health care professionals and to drive service improvements.

Aims and objectives  The aim of this study was to explore the influence of the cancer network partnership groups’ service user involvement activities on cancer care.

Design  This was a qualitative study involving documentary analysis and in-depth case studies of a sample of partnership groups.

Setting and participants  Five partnership groups were purposively selected as case studies from Macmillan regions across the UK; documents were collated from a further five groups. Forty people, including core group members and key stakeholders in cancer services, were interviewed.

Results and conclusions  The evidence from this study suggests that cancer network partnership groups are at their most influential at ‘grass roots’ level – contributing to patient information resources, enhancing access to services, and improving care environments. While such improvements are undoubtedly important to patients, the groups’ aim is to influence strategic changes, for example in cancer care commissioning or macro-level policy decision-making. The evolution of open, participatory relationships between service users and professionals, and recognition of the value of experiential knowledge are seen as key factors in influencing cancer care. The provision of dedicated resources to strengthen service user involvement activities is also vital.

Patients’ attitudes towards the involvement of medical students during induction of regional anesthesia

Interactive Infographic of the World's Best Countries - Newsweek

Note: includes healthcare but a variety of other indicators - interesting

louisgray.com: Social Me Me Me Me Me Media

Experiencing genetic counselling for hereditary cancers: the client's perspective - European Journal of Cancer Care - Wiley Online Library

Second-line treatment of first relapse recurrent ovarian cancer - Australian and New Zealand Journal of Obstetrics and Gynaecology - abstract

JCO: Lettter: Risk of Arterial Thrombosis Not Increased by Sorafenib or Sunitinib

Note: analyzing the research including a reference to Avastin

U.S. FDA - Cracking Down on Health Fraud - "Natural Healer"

‘Natural Healer' Convicted

In August 2006, a federal judge sentenced John E. Curran to 12.5 years in prison for fraud and money laundering. Promoting himself as a natural healer and posing as a medical doctor, Curran operated the Northeastern Institute for Advanced Natural Healing in Providence, R.I. He made false claims about his qualifications, educational background, and training.
Curran sold bogus products called "E-water" and "Green Drink." In promotional materials, Curran claimed to have cured people of cancer. One 17-year-old girl with ovarian cancer reportedly drank only Green Drink, a powdered vegetable drink, in the last weeks of her life.
In other instances, Curran used scare diagnosis tactics so that he could prescribe the phony cures to healthy people. Curran sold about 1.4 million dollars' worth of treatment and products after making his false diagnoses. He told patients they had "live parasites" in their blood, reduced blood cell counts, and ruined immune systems.